Arakawa et al. “Formation of heterodimers from three neurotrophins, nerve growth factor, neurotrophin-3, and brain-derived neurotrophic factor” J Biol Chem, 269, pp. 27833-27839 (1994). |
Chan et al., “A murine cytokine fusion toxin specifically targeting the murine GM-CSF receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells” Blood, 86, pp. 2732-2740 (1995). |
Chan et al., “Reactivity of murine cytokine fusion toxin, diphtheria toxin390-murine interleukin-3 (DT390-mIL-3), with bone marrow progenitor cells” Blood, 88, pp. 1445-1446 (1996). |
Eriksson et al., “A cavity-containing mutant of T4 lysozyme is stabilized by buried benzene” Nature, 355, pp. 371-373 (1992). |
Eriksson et al., “Refined structure of bovine carbonic anhydrase III at 2.0 Å resolution” Proteins, 16, pp. 29-42 (1993). |
Eriksson et al., “Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences” J. Mol. Biol., 229, pp. 747-769 (1993). |
Fulda et al., “Antiproliferative potential of cytostatic drugs on neuroblastoma cell in vitro” European J. Cancer, 31A, 616-21 (1995). |
Herrmann et al., “Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA” Mol. Biol. Cell, 4, pp. 1205-1216 (1993). |
Kita et al., “Contribution of the surface free energy perturbation to protein-solvent interactions” Biochemistry, 33, pp. 15178-15189 (1994). |
Kleywegt et al., Acta Crystallogr., D50, pp. 178-185 (1994). |
Matthews et al., “Studies on protein stability with T4 lysozyme” Adv. Protein Chem., 46, pp. 249-278 (1995). |
McDonald et al. “New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor” Nature, 354, pp. 411-414 (1991). |
Morton et al., “Energetic origins of specificity of ligand binding in an interior nonpolar cavity of T4 lysozyme” Biochemistry, 34, pp. 8564-8575 (1995). |
Morton et al., “Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity” Biochemistry, 34, pp. 8576-8588 (1995). |
Nakagawara et al., “Expression and function of TRK-B and BDNF in human neuroblastomas” Mol. Cell Biol., 14, pp. 759-767 (1994). |
Or et al., “Effects of competitive sodium-like antagonists on Na, K-ATPase suggest that cation occlusion from the cytoplasmic surface occurs in two steps” J. Biol. Chem., 268, pp. 16929-16937 (1993). |
Panayotatos et al., “Localization of Functional Receptor Epitopes on the Structure of Ciliary Neurotrophic Factor Indicates a Conserved, Function-related Epitope Topography among Helical Cytokines” J. Biol. Chem., 270, pp. 14007-14014 (1995). |
Panayotatos et al., “Recombinant human CNTF Receptor a: Production, Binding Stoichiometry and Characterization of Its Activity as a Diffusible Factor” Biochemistry, 33, pp. 5813-5818 (1994). |
Pedersen et al., “Cavity mutants of Savinase. Crystal structures and differential scanning calorimetry experiments give hints of the function of the buried water molecules in subtilisins” J. Mol. Biol., 242, pp. 193-202 (1994). |
Radziejewski C. and Robinson R. C. “Heterodimers of the neurotrophic factors: formation, isolation, and differential stability” Biochemistry, 32, 13350-6 (1993). |
Robinson et al., “Structure of the Brain Derived Neurotrophic Factor/Neurotrophia 3 Heterodimer” Biochemistry, 34, pp. 4139-4136 (1995). |
Weiner, “The role of growth factor receptors in central nervous system development and neoplasia” Neurosurgery, 37, pp. 179-194 (1995). |